Journal
/
Recherche en cancérologie
/
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Journal JoVE
Recherche en cancérologie
This content is Free Access.
Journal JoVE Recherche en cancérologie
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

DOI:
10.3791/63039-v

•

08:52 min

•

November 22, 2021

•

, , ,
1Department of Medicine,University of California, San Francisco, 2Helen Diller Family Comprehensive Cancer Center,University of California, San Francisco, 3Department of Cellular and Molecular Pharmacology,University of California, San Francisco

Chapitres

  • 00:04Introduction
  • 01:05Generating Single-Cell Suspension
  • 02:38Cell Seeding
  • 04:39Drug Treatment
  • 05:37Readout by Luminescence-Based Survival Assay
  • 06:52Results: The Analysis of Treatment Response of EGFR-Mutant NSCLC Organoid Model to Osimertinib
  • 08:18Conclusion

Summary

Traduction automatique

Traduction automatique

This protocol describes a standardized evaluation of drug sensitivities to targeted signaling inhibitors in NSCLC patient-derived organoid models.

Tags

OrganoidsEGFR-mutant NSCLCTargeted TherapiesMatrigelCell CultureDissociationTrypsinizationCentrifugationCell CountingCell Suspension96-well Plate

Article

Embed

AJOUTER À LA PLAYLIST

Usage Statistics

Vidéos Connexes

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

High-sensitivity Detection of Micrometastases Generated by GFP Lentivirus-transduced Organoids Cultured from a Patient-derived Colon Tumor

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids

Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs

Generation and Culturing of High-Grade Serous Ovarian Cancer Patient-Derived Organoids

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays

Establishment and Culture of Patient-Derived Breast Organoids

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing

Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma

Read Article